MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 14.00
0.00 (0.00%)
Oct 30, 2026, 1:48 PM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 764.46 million as of October 30, 2026. It is the 34,399th most valuable company in the world and the 2,074th biggest in Taiwan. Its market cap has decreased by 30.52% in one year.
Market Cap
764.46M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,074 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 764.46M, a decrease of -63.83%. That is a compound annual growth rate of -18.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 906.09M | 12.45% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Level Biotechnology | 993.06M |
| BiOptic | 992.66M |
| Holy Stone Healthcare | 992.62M |
| TCI GENE | 952.51M |
| GeneReach Biotechnology | 949.53M |
| Meribank Biotech | 865.70M |
| Lukas Biomedical | 736.99M |
| NatureWise Biotech & Medicals | 736.54M |